Papers authored by Deschemin JC

Collect these papers and discover other ones on Labmeeting. Learn more.
Hepcidin targets ferroportin for degradation in hepatocytes.
+ cite this
+ View Abstract
Ramey G, Deschemin JC, Durel B, Canonne-Hergaux F, Nicolas G, and Vaulont S
Haematologica 95(3):501-4, 2010 Mar - Who cited this? | PubMed ID: 19773263 | Fulltext
Recommend
Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes.
+ cite this
+ View Abstract
Ramey G, Deschemin JC, and Vaulont S
Haematologica 94(6):765-72, 2009 Jun - Who cited this? | PubMed ID: 19454495 | Fulltext
Recommend
Pro-hepcidin is unable to degrade the iron exporter ferroportin unless maturated by a furin-dependent process.
+ cite this
+ View Abstract
Gagliardo B, Kubat N, Faye A, Jaouen M, Durel B, Deschemin JC, Canonne-Hergaux F, Sari MA, and Vaulont S
Journal of hepatology 50(2):394-401, 2009 Feb - Who cited this? | PubMed ID: 19070914 | Fulltext
Recommend
Spontaneous and Fas-induced apoptosis of low-grade MDS erythroid precursors involves the endoplasmic reticulum.
+ cite this
+ View Abstract
Gyan E, Frisan E, Beyne-Rauzy O, Deschemin JC, Pierre-Eugene C, Randriamampita C, Dubart-Kupperschmitt A, Garrido C, Dreyfus F, Mayeux P, Lacombe C, Solary E, and Fontenay M
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, 2008 Jul 10 - Who cited this? | PubMed ID: 18615109 | Fulltext
Recommend
Production of biologically active forms of recombinant hepcidin, the iron-regulatory hormone.
+ cite this
+ View Abstract
Gagliardo B, Faye A, Jaouen M, Deschemin JC, Canonne-Hergaux F, Vaulont S, and Sari MA
The FEBS journal, 2008 Jun 14 - Who cited this? | PubMed ID: 18557934 | Fulltext
Recommend
Recombinant human IFN-alpha inhibits cerebral malaria and reduces parasite burden in mice.
+ cite this
+ View Abstract
Vigário AM, Belnoue E, Grüner AC, Mauduit M, Kayibanda M, Deschemin JC, Marussig M, Snounou G, Mazier D, Gresser I, and Rénia L
Journal of immunology (Baltimore, Md. : 1950) 178(10):6416, 2007 May 15 - Who cited this? | PubMed ID: 17475871 | Fulltext
Recommend
Pathogenic T cells in cerebral malaria.
+ cite this
+ View Abstract
Rénia L, Potter SM, Mauduit M, Rosa DS, Kayibanda M, Deschemin JC, Snounou G, and Grüner AC
International journal for parasitology 36(5):547-54, 2006 May 1 - Who cited this? | PubMed ID: 16600241 | Fulltext
Recommend
Species-specific inhibition of cerebral malaria in mice coinfected with Plasmodium spp.
+ cite this
+ View Abstract
Voza T, Vigário AM, Belnoue E, Grüner AC, Deschemin JC, Kayibanda M, Delmas F, Janse CJ, Franke-Fayard B, Waters AP, Landau I, Snounou G, and Rénia L
Infection and immunity 73(8):4777-86, 2005 Aug - Who cited this? | PubMed ID: 16040990 | Fulltext
Recommend
CCR5 deficiency decreases susceptibility to experimental cerebral malaria.
+ cite this
+ View Abstract
Belnoue E, Kayibanda M, Deschemin JC, Viguier M, Mack M, Kuziel WA, and Rénia L
Blood 101(11):4253-9, 2003 Jun 1 - Who cited this? | PubMed ID: 12560237 | Fulltext
Recommend
On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria.
+ cite this
+ View Abstract
Belnoue E, Kayibanda M, Vigario AM, Deschemin JC, van Rooijen N, Viguier M, Snounou G, and Rénia L
Journal of immunology (Baltimore, Md. : 1950) 169(11):6369-75, 2002 Dec 1 - Who cited this? | PubMed ID: 12444144 | Fulltext
Recommend
Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo.
+ cite this
+ View Abstract
Le Gal FA, Avril MF, Bosq J, Lefebvre P, Deschemin JC, Andrieu M, Dore MX, and Guillet JG
The Journal of investigative dermatology 117(6):1464-70, 2001 Dec - Who cited this? | PubMed ID: 11886510 | Fulltext
Recommend
Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection.
+ cite this
+ View Abstract
Dalod M, Dupuis M, Deschemin JC, Goujard C, Deveau C, Meyer L, Ngo N, Rouzioux C, Guillet JG, Delfraissy JF, Sinet M, and Venet A
The Journal of clinical investigation 104(10):1431-9, 1999 Nov - Who cited this? | PubMed ID: 10562305 | Fulltext
Recommend
Broad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8(+) responses in HIV type 1-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy.
+ cite this
+ View Abstract
Dalod M, Dupuis M, Deschemin JC, Sicard D, Salmon D, Delfraissy JF, Venet A, Sinet M, and Guillet JG
Journal of virology 73(9):7108-16, 1999 Sep - Who cited this? | PubMed ID: 10438796 | Fulltext
Recommend
Altered ex vivo balance between CD28+ and CD28- cells within HIV-specific CD8+ T cells of HIV-seropositive patients.
+ cite this
+ View Abstract
Dalod M, Sinet M, Deschemin JC, Fiorentino S, Venet A, and Guillet JG
European journal of immunology 29(1):38-44, 1999 Jan - Who cited this? | PubMed ID: 9933084 | Fulltext
Recommend
Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapy.
+ cite this
+ View Abstract
Dalod M, Harzic M, Pellegrin I, Dumon B, Hoen B, Sereni D, Deschemin JC, Levy JP, Venet A, and Gomard E
The Journal of infectious diseases 178(1):61-9, 1998 Jul - Who cited this? | PubMed ID: 9652424 | Fulltext
Recommend



Search Google Scholar for Deschemin JC

Join Labmeeting

  • Organize and search your PDF collection
  • Collect papers
  • Search millions of papers
  • Keep up to date with paper alerts
  • Read your papers from anywhere
  • Recommend papers to colleagues
  • Manage your lab
Sign Up

Join Labmeeting

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.


Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!